Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
3.64M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
616K
-
Shares change
-
-316K
-
Total reported value, excl. options
-
$1.71M
-
Value change
-
-$910K
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$2.78
Significant Holders of KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) as of Q3 2025
21 filings reported holding KPRX - KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value as of Q3 2025.
KIORA PHARMACEUTICALS INC - Common Stock, $0.01 par value (KPRX) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 616K shares
of 3.64M outstanding shares and own 16.92% of the company stock.
Largest 10 shareholders include ADAR1 Capital Management, LLC (168K shares), Nantahala Capital Management, LLC (156K shares), Stonepine Capital Management, LLC (141K shares), CITADEL ADVISORS LLC (44.6K shares), DRW Securities, LLC (36.9K shares), VANGUARD GROUP INC (20.9K shares), GEODE CAPITAL MANAGEMENT, LLC (18.9K shares), RENAISSANCE TECHNOLOGIES LLC (12.4K shares), TWO SIGMA INVESTMENTS, LP (12K shares), and CITIGROUP INC (3.88K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.